INSM Competitors & Alternatives
Compare Insmed Inc with similar stocks in the same industry
Biotechnology
INSM
Main Stock$131.10
Tradestie Score
48
Market Cap
$31.13B
Revenue Growth
2.3%
Analyst Upside
+49.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$93.67
|
$24.57B | - | 52 | Compare |
|
GMAB
Genmab A/S ADS
|
$31.25
|
$19.56B | 22.0 | 56 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.56
|
$16.93B | 15.3 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$56.77
|
$15.70B | 30.2 | 51 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.96
|
$15.22B | - | 56 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$255.41
|
$12.36B | 28.0 | 56 | Compare |
|
EXEL
Exelixis Inc
|
$54.07
|
$11.09B | 18.5 | 45 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.34
|
$10.76B | - | 49 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$59.17
|
$10.74B | - | 49 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$63.81
|
$10.53B | 43.7 | 58 | Compare |
More INSM Analysis
Data updated: Aug 07, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry